Skip to content

(NOD)-Like Receptors CARD Domain-Containing 4 Levels in Individuals With Periodontitis

Evaluation of (NOD)-Like Receptors CARD Domain-containing 4 Levels in Individuals With Healthy and Periodontal Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04850768
Enrollment
75
Registered
2021-04-20
Start date
2021-04-16
Completion date
2021-09-20
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis, Healthy, Periodontitis

Keywords

NLRC4

Brief summary

NLRC4, an inflammasome , is a cytosolic multiprotein complex involved in the initiation and modulation of the immune response. Periodontitis is a chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. It has been said that proinflammatory cytokines released in the microenvironment of periodontitis can increase the expression of NLRC4 inflammasome genes. The authors think that NLRC4 may play a role in the periodontitis. The aim of this study is to compare the NLRC4, IL-1β and IL-10 levels of healthy and periodontitis individuals.

Detailed description

Periodontitis is a destructive chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. Inflammasomes are cytosolic multiprotein complex involved in the initiation and modulation of the immune response. Interleukine -1β ( IL-1β ) levels are associated with periodontal destruction in the pathogenesis of periodontal disease. Interleukine-10 (IL-10) has been reported to decrease periodontal disease progression rate. Gingival crevicular fluid shows the cellular response in the periodontium. The most important host-related ingredients are inflammatory markers, including cytokines, enzymes, and interleukins. Saliva analysis is used in the diagnosis of systemic conditions as well as in the diagnosis of oral pathologies. Both NLRC4 and NLRP3 inflammasomes have been shown to play an important role in the induction of interleukin-1β secretion. Periodontitis is induced by a complex microbial biofilm containing multiple Gram-positive and Gram-negative bacteria (including flagellate microorganisms) capable of activating a large number of NLRs. It has been said that proinflammatory cytokines released in the microenvironment of periodontitis can increase the expression of NLRC4 inflammasome genes. Evidence on the role of inflammasomes in periodontal disease is still very poor. The aim of this study is to compare the NLRC4, IL-1β and IL-10 levels of healthy and periodontitis individuals.

Interventions

OTHERSaliva

individuals' saliva samples will be collected and transferred to eppendorf tubes. Until biochemical analysis is carried out will be stored in -80ºC.

GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes.Until biochemical analysis is carried out will be stored in -80ºC.

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* systemically healthy individuals who does not have a disease under treatment, individuals without regular systemic medication

Exclusion criteria

* smoking receiving periodontal treatment in the last 6 months pregnancy menopausal or menstrual period

Design outcomes

Primary

MeasureTime frameDescription
IL-1β levelsthrough study completion, an average of 6 monthssaliva and DOS levels
IL-10 levelsthrough study completion, an average of 6 monthssaliva and DOS levels
NLRC4through study completion, an average of 6 monthssaliva and DOS levels

Secondary

MeasureTime frameDescription
Plaque Indexup to 20 weeksSilness-Löe
Probing Depthup to 20 weeksmillimeter
Bleeding on Probeup to 20 weeksAinamo&Bay

Countries

Turkey (Türkiye)

Contacts

Primary ContactAyşe Toraman, Dr
draysetoraman@gmail.com05385025422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026